Apaziquone

N/A

Report date: 2024/01/16 11:02:08
NME

Base Information

Drug NameApaziquone
Drug Alias Nameapaziquone阿帕齐醌apazicuonaapaziquonumNeoquin +[12] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[8] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSpectrum Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHandok IncAllergan PlcSpectrum Pharmaceuticals Inc +[4] 
Active IndicationsN/A
Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG